• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Averhealth logo

Averhealth

Substance use monitoring and treatment solutions.

  • Court Solutions
    • Why Averhealth
    • Our Laboratory
    • Technology
  • Blog
  • Knowledge Hub
    • Press Releases
    • Testimonials
    • Newsletters
    • Annual Reports
    • Education
      • White Papers
    • Podcast
    • Webinars
  • Averhealth Academy
  • About
    • About Averhealth
    • Leadership
    • Careers
    • Job Openings
    • Certifications & Licenses
    • Our Partners
    • Conferences
    • Contact
    • Locations
    • Financial Affordability in Recovery (FAIR) Application
  • Log In
    • Provider
    • Patient
Michele Glinn

Michele Glinn

The Twin Pandemic: Substance Use and Overdoses on the Rise

01.12.22

It may be a new year but, sadly, the heartbreak continues. The U.S. lost more than 815,000 lives to COVID-19 through the end of 2021.

Read More

Mental Health and SUD – A Co-Occurring Disorder on the Rise Since 2020

07.29.21

male patient with co-occurring disorder

As the US continues to struggle with the aftermath of COVID-19, America has experienced an increase in the number of overdose deaths as a result of isolation and lack of support for those individuals with mental health and substance use disorders (SUD). From May 2019 to May 2020, there were over 81,000 drug overdose deaths […]

Read More

How EtG/EtS testing Detects Ethanol in Alcohol Better Than Simple Alcohol Testing

04.27.21

DUI Court that also test for drugs

Globally, up to 3.3 million people die every year due to alcohol use disorder. This legal drug is one of the most commonly abused substances, yet it is one of the more difficult substances to detect. When you partner with a drug testing vendor, they can use EtG (ethyl glucuronide) and EtS (ethyl sulfate) testing […]

Read More

The Importance of Lab-Based Testing for Accuracy and Reliability

02.19.21

Averhealth employees working in laboratory in St. Louis, MO

Evidence-based drug testing practices serve a critical role in helping people to navigate the intersection of criminal justice programs and healthcare. Many courts and probation departments understand the crucial importance of random testing but choosing a substance use monitoring partner that has a reliable process and the best testing technology is just as important. Averhealth’s […]

Read More

Evidence-Based Practices for Substance Use Disorder Testing

09.21.20

Averhealth lab employee in St. Louis, MO

People with substance use disorders often do not self-disclose substance use reliably. Studies conducted in substance use treatment, primary medical care and emergency room settings have reported that between 25% and 85% of individuals testing positive for illicit drugs or alcohol denied recent usage (Bagley et al., 2018; Chen et al., 2006; Harris et al., […]

Read More

Evidence-Based Practices During this Unprecedented Time

03.20.20

orange and blue test tubes

Richmond, Va. – Determining the optimal specimen type to test for is dependent on a variety of factors. In order to properly test for substance use, it is important and helpful to know the different facets of each specimen you have the ability to test. Generally, choosing a specimen is determined by the type of […]

Read More
  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Go to Next Page »

Primary Sidebar

BLOG SEARCH

Join Our Newsletter

Be the first to find out when we have exclusive news, articles or upcoming events to share.

Footer

  • Facebook
  • LinkedIn
 
866. 680. 3106
info@Averhealth.com

Newsletter Signup

Averhealth, Avertest, Aversys, and the associated logos and all associated marks are registered trademarks or service marks of Avertest, LLC.
© 2026 Avertest, LLC. All rights reserved.
The information provided on this website, including articles, laboratory guides, and compliance resources, is for educational and informational purposes only. It does not constitute professional medical advice, diagnosis, or treatment, nor does it establish a patient-provider relationship.

  • Lab Certifications
  • Non-Discrimination Notice
  • Compliance
  • Privacy Policy
  • texas Department of information resources
  • SAM registration